FDA Clearance Tracker · P050019
CAROTID WALLSTENT MONORAIL ENDOPROSTHESIS
Last checked: Nov 20, 2026Latest source record: Oct 23, 2008 (this decision)Source: openFDAMethods & limitations
Decided
Oct 23, 2008
Approved
Time to decision
1,248 days
Received May 24, 2005. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P050019
- Device name
- CAROTID WALLSTENT MONORAIL ENDOPROSTHESIS
- Applicant
- Boston Scientific Corp
- Applicant location
- Maple Grove, MN
- Received
- May 24, 2005
- Decided
- Oct 23, 2008
- Decision
- Approved
- Supplements
- 41 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Stent, carotid (NIM)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE CAROTID WALLSTENT MONORAIL ENDOPROSTHESIS. THE DEVICE, USED INCONJUNCTION WITH THE BOSTON SCIENTIFIC EMBOLIC PROTECTION SYSTEM, IS INDICATED FOR THE TREATMENTOF PATIENTS AT HIGH RISK FOR ADVERSE EVENTS FROM CAROTID ENDARTERECTOMY DUE TO EITHER ANATOMIC OR COMORBID CONDITIONS WHO REQUIRE CAROTID REVASCULARIZATION IN THE TREATMENT OF IPSILATERAL ORBILATERAL CAROTID ARTERY DISEASE AND MEET THE CRITERIA OUTLINED BELOW:1) PATIENTS WITH NEUROLOGICAL SYMPTOMS AND > 50% STENOSIS OF THE COMMON, INTERNAL CAROTIDARTERY AND/OR THE BIFURCATION BY ULTRASOUND OR ANGIOGRAM, OR PATIENTS WITHOUT NEUROLOGICALSYMPTOMS AND > 80% STENOSIS OF THE COMMON, INTERNAL CAROTID ARTERY AND/OR THEBIFURCATION BY ULTRASOUND OR ANGIOGRAM, AND;2) PATIENTS WITH A REFERENCE VESSEL DIAMETER WITHIN THE RANGE OF 4.0 MM AND 9.0 MM AT THETARGET LESION.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NIM. The earliest in FDA's data is P040012, decided Aug 30, 2004.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Boston Scientific Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P130030 · Decided Mar 10, 2026 · 4,453 days after receipt
Device type: STENT, CORONARY (MAF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.